New injection for arthritis pain enters early human testing
NCT ID NCT07230353
First seen Nov 17, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This early-stage study tests a new drug called plamotamab in 68 adults with moderate to severe rheumatoid arthritis who have not responded well to other treatments. The main goal is to check the drug's safety and side effects when given as an injection under the skin. Researchers will also measure how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Xencor Investigative Site
RECRUITINGTbilisi, Georgia
-
Xencor Investigative Site
RECRUITINGChisinau, Moldova
-
Xencor Investigative Site
RECRUITINGAuckland, New Zealand
Conditions
Explore the condition pages connected to this study.